Literature DB >> 10595413

Matrix protein of Chandipura virus inhibits transcription from an RNA polymerase II promoter.

A Taylor1, A J Easton, A C Marriott.   

Abstract

Chandipura virus (CHPV) is a Vesiculovirus, related to, but phylogenetically distinct from, vesicular stomatitis virus (VSV). The matrix protein of VSV, as well as its role in virus assembly, inhibits the transcription from promoters for host RNA polymerases I and II. Cloning and expression of the matrix protein of CHPV in human cells showed that this protein is also functional in its inhibitory effect on transcription of a reporter gene from the cytomegalovirus immediate-early promoter, despite sharing only 28% amino acid sequence identity with the matrix protein of VSV.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10595413     DOI: 10.1023/a:1008188730975

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.198


  23 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Genome RNA terminus conservation and diversity among vesiculoviruses.

Authors:  S T Nichol; J J Holland
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

3.  The relationship of Piry virus to other vesiculoviruses: a re-evaluation based on the glycoprotein gene sequence.

Authors:  G Brun; X Bao; L Prevec
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

4.  Interference as a measure of cross-relationships in the vesicular stomatitis group of rhabdo viruses.

Authors:  J Crick; F Brown
Journal:  J Gen Virol       Date:  1973-01       Impact factor: 3.891

Review 5.  Negative-strand virus M and retrovirus MA proteins: all in a family?

Authors:  J Lenard
Journal:  Virology       Date:  1996-02-15       Impact factor: 3.616

6.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.

Authors:  J D Thompson; D G Higgins; T J Gibson
Journal:  Nucleic Acids Res       Date:  1994-11-11       Impact factor: 16.971

7.  Sequences of Chandipura virus N and NS genes: evidence for high mutability of the NS gene within vesiculoviruses.

Authors:  P S Masters; A K Banerjee
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

8.  Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III.

Authors:  M Ahmed; D S Lyles
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

9.  A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding.

Authors:  R N Harty; J Paragas; M Sudol; P Palese
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

10.  Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.

Authors:  D S Lyles; M O McKenzie; M Ahmed; S C Woolwine
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

View more
  4 in total

Review 1.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

2.  Multiple vesiculoviral matrix proteins inhibit both nuclear export and import.

Authors:  J M Petersen; L S Her; J E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Crystal structure of vesicular stomatitis virus matrix protein.

Authors:  Martin Gaudier; Yves Gaudin; Marcel Knossow
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

4.  Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.

Authors:  Satyendra Kumar; Vidya A Arankalle
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.